Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Revenue

Emergent BioSolutions had revenue of $140.90M in the quarter ending June 30, 2025, a decrease of -44.68%. This brings the company's revenue in the last twelve months to $851.60M, down -22.74% year-over-year. In the year 2024, Emergent BioSolutions had annual revenue of $1.04B, down -0.54%.

• Revenue (ttm): $851.60M
• Revenue Growth: -22.74%
• P/S Ratio: 0.53
• Revenue / Employee: $946,222
• Employees: 900
• Market Cap: 442.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.04B	-5.70M	-0.54%
Dec 31, 2023	1.05B	-68.20M	-6.10%
Dec 31, 2022	1.12B	-656.10M	-36.99%
Dec 31, 2021	1.77B	196.30M	12.45%
Dec 31, 2020	1.58B	471.30M	42.61%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.